CIK 0000948320 · Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760238453
- Phone
- (866) 351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-22 | Galluppi Stefan Chief Innovation Officer | Grant or award | +30,000 | 110,449 | ||
| 2025-08-22 | FRIEDEMAN JESSICA Chief Marketing Officer | Grant or award | +50,000 | 220,000 | ||
| 2025-08-22 | Benathen Marc David Chief Financial Officer | Grant or award | +87,000 | 426,554 | ||
| 2025-08-22 | Alvarez Nicholas P Chief Acquisition Officer | Grant or award | +100,000 | 680,000 | ||
| 2025-08-22 | Dray Shayna Webb Chief Operating Officer | Grant or award | +30,000 | 295,000 | ||
| 2025-07-27 | Dray Shayna Webb Chief Operating Officer | Grant or award | +50,000 | 265,000 | ||
| 2025-07-01 | Schreiber Justin Chairman and CEO | Sale 10b5-1 | −25,000 | $9.99 | $250K | 2,475,721 |
| 2025-07-01 | Schreiber Justin Chairman and CEO | Sale 10b5-1 | −25,000 | $13.38 | $334K | 2,500,721 |
| 2025-06-17 | Benathen Marc David Chief Financial Officer | Sale 10b5-1 | −50,000 | $14.01 | $700K | 339,554 |
| 2025-06-16 | Benathen Marc David Chief Financial Officer | Sale 10b5-1 | −75,000 | $13.09 | $982K | 389,554 |
| 2025-06-13 | Yecies Eric Harold Chief Legal Officer & GC | Sale | −15,000 | $12.25 | $184K | 16,100 |
| 2025-06-13 | Galluppi Stefan Chief Innovation Officer | Sale 10b5-1 | −85,000 | $12.38 | $1.1M | 80,449 |
| 2025-06-02 | Schreiber Justin Chairman and CEO | Sale 10b5-1 | −25,000 | $12.47 | $312K | 2,525,721 |
| 2025-05-02 | Schreiber Justin Chairman and CEO | Sale 10b5-1 | −3,005 | $7.50 | $23K | 2,550,721 |
| 2025-05-01 | Schreiber Justin Chairman and CEO | Sale 10b5-1 | −21,995 | $7.53 | $166K | 2,553,726 |
| 2025-04-29 | Schreiber Justin Chairman and CEO | Sale 10b5-1 | −50,000 | $7.78 | $389K | 2,575,721 |
| 2025-03-31 | STAN MARIA E. Chief Accounting Officer | Grant or award | +20,000 | 187,500 | ||
| 2025-03-31 | STAN MARIA E. Chief Accounting Officer | Grant or award | +20,000 | 207,500 | ||
| 2025-03-31 | Alvarez Nicholas P Chief Acquisition Officer | Grant or award | +75,000 | 580,000 | ||
| 2025-03-31 | Wijnker Dennis Chief Technology Officer | Grant or award | +25,000 | 150,000 |
Page 2 of 8 · 146 trades